American Society of Hematology

Schedule and Program for the ASH Meeting on Hematologic Malignancies

The following program corresponds to the 2019 ASH Meeting on Hematologic Malignancies.

7:00 a.m.
Registration, Breakfast, and Exhibits
7:45 a.m.
Welcome and Opening Remarks
8:00 a.m.
How I Treat Young Adults with Acute Lymphoblastic Leukemia
Anjali Advani, MD, Cleveland Clinic
8:30 a.m.
How I Treat Acute Lymphoblastic Leukemia with Incorporation of Novel Therapies
Jae H. Park, MD, Memorial Sloan Kettering Cancer Center
9:00 a.m.
How I Diagnose Patients with AML Based on Minimal Residual Disease Testing
Brent Wood, MD, PhD, University of Washington
9:30 a.m.
Panel Discussion with Drs. Advani, Park, and Wood
10:00 a.m.
Networking Coffee Break and Exhibits
10:30 a.m.
Special Education Program Session: Controversial Cases in AML
Gail Roboz, MD, Weill Cornell Medicine
Jessica Altman, MD, Northwestern University
Harry Erba, MD, PhD, Duke University
11:30 a.m.
Special Education Program Session Panel Discussion with Drs. Roboz, Altman, and Erba
12:00 p.m.
Lunch with the Experts (General Lunch Available)
1:15 p.m.
How I Treat Patients with Low Grade Myelodysplastic Syndromes
Amer Zeidan, MD, Yale University
1:45 p.m.
How I Treat Patients with High Grade Myelodysplastic Syndromes
Amy DeZern, MD, Johns Hopkins University
2:15 p.m.
Panel Discussion with Drs. Zeidan and DeZern
2:45 p.m.
Networking Coffee Break and Exhibits
3:15 p.m.
How I Approach CML TKI Discontinuation
Neil Shah, MD, PhD, University of California – San Francisco
3:45 p.m.
How I Identify and Treat MF Patients With Ruxolitinib Failure
John Mascarenhas, MD, Mount Sinai School of Medicine
4:15 p.m.
Panel Discussion with Drs. Shah and Mascarenhas
4:45 p.m.
How I Treat Newly Diagnosed Hodgkin Lymphoma
Andy Evens, DO, Rutgers University
5:15 p.m.
How I Treat Relapsed Hodgkin Lymphoma
Stephen Ansell, MD, PhD, Mayo Clinic
5:45 p.m.
Panel Discussion with Drs. Evens and Ansell
6:15 p.m.
Program Concludes for the Day
7:00 a.m.
Registration, Breakfast, and Exhibits
7:45 a.m.
Welcome and Opening Remarks
8:00 a.m.
How I Treat Newly Diagnosed, Relapsed, and Transformed CLL Patients
Jose Leis, MD, PhD, Mayo Clinic
8:30 a.m.
DLBCL – Does the Molecular Classification Really Inform Therapy?
Kieron Dunleavy, MD, George Washington University
9:00 a.m.
T-cell Lymphoma – How Should I Use New Agents in My Practice?
Neha Mehta-Shah, MD, Washington University in St. Louis
9:30 a.m.
Panel Discussion with Drs. Dunleavy, Mehta-Shah, and Leis
10:00 a.m.
Networking Coffee Break and Exhibits
10:30 a.m.
How I Treat Follicular Lymphoma
John Leonard, MD, Weill Cornell Medicine
11:00 a.m.
Marginal Zone Lymphoma – What Does the Biology Teach Us?
Sonali Smith, MD, University of Chicago
11:30 a.m.
Mantle Cell Lymphoma – What Treatment Should I Choose for A Newly Diagnosed Patient?
Brad Kahl, MD, Washington University School of Medicine in St. Louis
12:00 noon
Panel Discussion with Drs. Leonard, Smith, and Kahl
12:30 p.m.
Lunch with the Experts (General Lunch Available)
1:45 p.m.
How I Treat Smoldering Myeloma
Irene Ghobrial, MD, Dana-Farber Cancer Institute
2:15 p.m.
How I Treat Refractory Myeloma
Jesus Berdeja, MD, Sarah Cannon Research Institute
2:45 p.m.
Panel Discussion with Drs. Ghobrial and Berdeja
3:15 p.m.
Networking Coffee Break and Exhibits
3:45 p.m.
Special Education Program Session: Controversies in the Management of Newly Diagnosed Multiple Myeloma
S. Vincent Rajkumar, MD, Mayo Clinic
Michaela Liedtke, MD, Stanford University
Prashant Kapoor, MD, Mayo Clinic
4:45 p.m.
Special Education Program Session Panel Discussion with Drs. Rajkumar, Liedtke, and Kapoor
5:15 p.m.
Program Concludes
back to top